search

menu

  • Research Research
    • Where science meets inspired minds

    • Back
    • Research
    • Our Science
    • Research Groups
    • Facilities & Platforms
    • Clinical research
    • Find a researcher
    • Publications
    • Knowledge Transfer
  • Careers & study Careers & study
    • Become a leader in cancer research

    • Back
    • Careers & study
    • Vacancies
    • Faculty
    • Scientific staff
    • Scientific support staff
    • Postdoctoral fellows
    • PhD Students
    • Operational staff
    • Clinical fellows
    • Life in Amsterdam
    • Student internships
  • News & Events News & Events
    • Check out our stories and events

    • Back
    • News & Events
    • News
    • Media & Press
    • Calendar
  • About us About us
    • Maximum impact for cancer patients

    • Back
    • About us
    • Our vision
    • Organization
    • Collaborations
    • Responsible Research
    • Support us
    • Visit us
    • Contact us
  • Support us
Support us
  • Home
  • Publications
  • Research
  • Publications
  • Article

LiDAR-registered freehand SPECT combined with NIR-fluorescence enables spatial localisation of tracer-avid inguinal lymph nodes: A clinical feasibility study.

Rick W A Verdijk ,
Giusi Pisano ,
Matthias N van Oosterom ,
Evie de Groot ,
Helena Zuurdeeg ,
Oscar R Brouwer ,
Henk G van der Poel ,
Fijs W B van Leeuwen

Abstract

METHODS

Fourteen patients with penile cancer (25 cN0 groins; 3 cN1 groins) underwent radio- and fluorescence-guided lymph node (LN) surgery following preoperative lymphoscintigraphy and SPECT/CT. Resected specimens underwent conventional ex vivo assessment, followed by LiDAR-registered fhSPECT with co-registered NIR-fluorescence imaging. These 3D models were compared with conventional ex vivo assessments, preoperative imaging, and histopathological outcomes.

CONCLUSION

LiDAR-registered 3D surface mapping provided anatomical context to radioactive and fluorescent molecular imaging signals, enabling localisation of tracer-avid LNs in complex ex vivo ILND specimens. These findings support the feasibility of spatially augmented localisation of hybrid tracer uptake and warrant validation in larger studies.

RESULTS

In total, 40 solitary tracer-avid LNs and 3 ILND specimens underwent ex vivo assessment. LiDAR/fhSPECT localised radioactive hotspots in 38/40 solitary LNs, consistent with conventional gamma probe assessment, while both conventional and LiDAR-registered NIR-fluorescence imaging detected fluorescent signal in all 40 LNs. Among the 3 ILND procedures, preoperative SPECT/CT identified 6 tracer-avid hotspots within the anatomical resection template. Conventional gamma probe and NIR-fluorescence detected only 4 and 5 hotspots, respectively, whereas LiDAR/fhSPECT localised all 6 hotspots in the corresponding resected specimens. Histopathology identified 6 tumour-positive LNs, all of which were hybrid tracer-avid and effectively localised by LiDAR/fhSPECT.

PURPOSE

Conventional ex vivo molecular assessment of nodal specimens lacks three-dimensional (3D) spatial context, making localisation of tracer-avid sentinel nodes (SNs) within large en bloc inguinal lymph node dissection (ILND) specimens challenging. We evaluated the technical feasibility of combining light detection and ranging (LiDAR)-registered freehand SPECT (fhSPECT) with near-infrared (NIR) fluorescence imaging for spatially augmented localisation of hybrid tracer uptake in solitary SNs and SNs residing within ILND specimens.

More about this publication

European journal of nuclear medicine and molecular imaging

Publication date 21-07-2026

Full text links

Publisher website (DOI) 10.1007/s00259-026-08075-y
Europe PubMed Central 42477145
Pubmed 42477145

Where science meets inspired minds

Contact

Plesmanlaan 121
1066CX Amsterdam

020 512 9111 communicatie@nki.nl

Quick links

  • Vacancies
  • News
  • Contact us
  • Media & Press

Follow us on

Disclaimer
Privacy statement
Cookies
Change cookie settings

This site uses cookies

This website uses cookies to ensure you get the best experience on our website.